Search
- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus
“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.
- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome
Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.
- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects
Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.
- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease
OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .
- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials
For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.